(E)-3-(2-Fluoro-phenyl)-N-{(S)-1-[3-(6-fluoro-pyridin-3-yl)-phenyl]-ethyl}-acrylamide

ID: ALA361184

Chembl Id: CHEMBL361184

PubChem CID: 10270128

Max Phase: Preclinical

Molecular Formula: C22H18F2N2O

Molecular Weight: 364.39

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](NC(=O)/C=C/c1ccccc1F)c1cccc(-c2ccc(F)nc2)c1

Standard InChI:  InChI=1S/C22H18F2N2O/c1-15(26-22(27)12-10-16-5-2-3-8-20(16)23)17-6-4-7-18(13-17)19-9-11-21(24)25-14-19/h2-15H,1H3,(H,26,27)/b12-10+/t15-/m0/s1

Standard InChI Key:  UZXOICNXSPXWIT-PABFRNLHSA-N

Associated Targets(non-human)

Kcnq2 Voltage-gated potassium channel subunit Kv7.2 (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 364.39Molecular Weight (Monoisotopic): 364.1387AlogP: 4.92#Rotatable Bonds: 5
Polar Surface Area: 41.99Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.80CX LogD: 4.80
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.52Np Likeness Score: -1.20

References

1. L'Heureux A, Martel A, He H, Chen J, Sun LQ, Starrett JE, Natale J, Dworetzky SI, Knox RJ, Harden DG, Weaver D, Thompson MW, Wu YJ..  (2005)  (S,E)-N-[1-(3-heteroarylphenyl)ethyl]-3-(2-fluorophenyl)acrylamides: synthesis and KCNQ2 potassium channel opener activity.,  15  (2): [PMID:15603955] [10.1016/j.bmcl.2004.10.065]
2. Wu YJ, Conway CM, Sun LQ, Machet F, Chen J, Chen P, He H, Bourin C, Calandra V, Polino JL, Davis CD, Heman K, Gribkoff VK, Boissard CG, Knox RJ, Thompson MW, Fitzpatrick W, Weaver D, Harden DG, Natale J, Dworetzky SI, Starrett JE..  (2013)  Discovery of (S,E)-3-(2-fluorophenyl)-N-(1-(3-(pyridin-3-yloxy)phenyl)ethyl)-acrylamide as a potent and efficacious KCNQ2 (Kv7.2) opener for the treatment of neuropathic pain.,  23  (22): [PMID:24070783] [10.1016/j.bmcl.2013.08.092]

Source